312
Participants
Start Date
May 24, 2018
Primary Completion Date
March 31, 2020
Study Completion Date
March 31, 2020
Multiplex molecular diagnostic assay
To assess the added value and acceptability of a multiplexed molecular diagnostic assay in the identification of pathogens in patients presenting with bacteremia at hospitals in LMICs, and to assess health care providers' satisfaction with the assay.
Princess Marina Hospital, Gaborone
Foundation for Innovative New Diagnostics, Switzerland
OTHER